150 related articles for article (PubMed ID: 38067257)
1.
Miedema IHC; Wijngaarden JE; Pouw JEE; Zwezerijnen GJC; Sebus HJ; Smit E; de Langen AJ; Bahce I; Thiele A; Vugts DJ; Boellaard R; Huisman MC; Menke-van der Houven van Oordt CW
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067257
[TBL] [Abstract][Full Text] [Related]
2.
Jauw YWS; O'Donoghue JA; Zijlstra JM; Hoekstra OS; Menke-van der Houven van Oordt CW; Morschhauser F; Carrasquillo JA; Zweegman S; Pandit-Taskar N; Lammertsma AA; van Dongen GAMS; Boellaard R; Weber WA; Huisman MC
J Nucl Med; 2019 Dec; 60(12):1825-1832. PubMed ID: 31147401
[No Abstract] [Full Text] [Related]
3. Validation of simplified uptake measures against dynamic Patlak K
Wijngaarden JE; Huisman MC; Jauw YWS; van Dongen GAMS; Greuter HNJM; Schuit RC; Cleveland M; Gootjes EC; Vugts DJ; Menke-van der Houven van Oordt CW; Boellaard R
Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):1897-1905. PubMed ID: 36820891
[TBL] [Abstract][Full Text] [Related]
4. Immuno-PET Imaging to Assess Target Engagement: Experience from
Menke-van der Houven van Oordt CW; McGeoch A; Bergstrom M; McSherry I; Smith DA; Cleveland M; Al-Azzam W; Chen L; Verheul H; Hoekstra OS; Vugts DJ; Freedman I; Huisman M; Matheny C; van Dongen G; Zhang S
J Nucl Med; 2019 Jul; 60(7):902-909. PubMed ID: 30733323
[TBL] [Abstract][Full Text] [Related]
5. Optimal imaging time points considering accuracy and precision of Patlak linearization for
Wijngaarden JE; Huisman MC; Pouw JEE; Menke-van der Houven van Oordt CW; Jauw YWS; Boellaard R
EJNMMI Res; 2022 Sep; 12(1):54. PubMed ID: 36065038
[TBL] [Abstract][Full Text] [Related]
6. Non-specific irreversible
Wijngaarden JE; Jauw YWS; Zwezerijnen GJC; de Wit-van der Veen BJ; Vugts DJ; Zijlstra JM; van Dongen GAMS; Boellaard R; Menke-van der Houven van Oordt CW; Huisman MC
EJNMMI Res; 2024 Feb; 14(1):18. PubMed ID: 38358425
[TBL] [Abstract][Full Text] [Related]
7.
van der Veen EL; Giesen D; Pot-de Jong L; Jorritsma-Smit A; De Vries EGE; Lub-de Hooge MN
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33020241
[TBL] [Abstract][Full Text] [Related]
8. Radiation dosimetry of 89Zr-labeled chimeric monoclonal antibody U36 as used for immuno-PET in head and neck cancer patients.
Börjesson PK; Jauw YW; de Bree R; Roos JC; Castelijns JA; Leemans CR; van Dongen GA; Boellaard R
J Nucl Med; 2009 Nov; 50(11):1828-36. PubMed ID: 19837762
[TBL] [Abstract][Full Text] [Related]
9. Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?
Jauw YW; Menke-van der Houven van Oordt CW; Hoekstra OS; Hendrikse NH; Vugts DJ; Zijlstra JM; Huisman MC; van Dongen GA
Front Pharmacol; 2016; 7():131. PubMed ID: 27252651
[TBL] [Abstract][Full Text] [Related]
10. PET/CT Imaging of
Li W; Wang Y; Rubins D; Bennacef I; Holahan M; Haley H; Purcell M; Gantert L; Hseih S; Judo M; Seghezzi W; Zhang S; van der Veen EL; Lub-de Hooge MN; de Vries EGE; Evelhoch JL; Klimas M; Hostetler ED
Mol Imaging Biol; 2021 Apr; 23(2):250-259. PubMed ID: 33104972
[TBL] [Abstract][Full Text] [Related]
11.
Miedema IHC; Huisman MC; Zwezerijnen GJC; Grempler R; Pitarch AP; Thiele A; Hesse R; Elgadi M; Peltzer A; Vugts DJ; van Dongen GAMS; de Gruijl TD; Menke-van der Houven van Oordt CW; Bahce I
Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):2068-2080. PubMed ID: 36859619
[TBL] [Abstract][Full Text] [Related]
12. Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice.
Verel I; Visser GW; Boellaard R; Boerman OC; van Eerd J; Snow GB; Lammertsma AA; van Dongen GA
J Nucl Med; 2003 Oct; 44(10):1663-70. PubMed ID: 14530484
[TBL] [Abstract][Full Text] [Related]
13. Noise-Induced Variability of Immuno-PET with Zirconium-89-Labeled Antibodies: an Analysis Based on Count-Reduced Clinical Images.
Jauw YWS; Heijtel DF; Zijlstra JM; Hoekstra OS; de Vet HCW; Vugts DJ; Verheul HM; Boellaard R; Zweegman S; van Dongen GAMS; der Houven van Oordt CWM; Lammertsma AA; Huisman MC
Mol Imaging Biol; 2018 Dec; 20(6):1025-1034. PubMed ID: 29713958
[TBL] [Abstract][Full Text] [Related]
14. How to obtain the image-derived blood concentration from
Wijngaarden JE; Ahbari A; Pouw JEE; Greuter HNJM; Bahce I; Zwezerijnen GJC; Vugts DJ; van Dongen GAMS; Boellaard R; Menke-van der Houven van Oordt CW; Huisman MC
EJNMMI Phys; 2024 Feb; 11(1):16. PubMed ID: 38321232
[TBL] [Abstract][Full Text] [Related]
15. Application of
Stergiou N; Wuensche TE; Schreurs M; Mes I; Verlaan M; Kooijman EJM; Windhorst AD; Helboe L; Vergo S; Christensen S; Asuni AA; Jensen A; Van Dongen GAMS; Bang-Andersen B; Vugts DJ; Beaino W
Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1306-1317. PubMed ID: 36635462
[TBL] [Abstract][Full Text] [Related]
16. Cysteine-specific
Lee JH; Jung KH; Kim M; Lee KH
Front Immunol; 2022; 13():1017132. PubMed ID: 36591250
[TBL] [Abstract][Full Text] [Related]
17. Advancing
Wuensche TE; Stergiou N; Mes I; Verlaan M; Schreurs M; Kooijman EJM; Janssen B; Windhorst AD; Jensen A; Asuni AA; Bang-Andersen B; Beaino W; Dongen GAMS; Vugts DJ
Theranostics; 2022; 12(16):7067-7079. PubMed ID: 36276653
[TBL] [Abstract][Full Text] [Related]
18. [
Zettlitz KA; Tsai WK; Knowles SM; Salazar FB; Kobayashi N; Reiter RE; Wu AM
Mol Imaging Biol; 2020 Apr; 22(2):367-376. PubMed ID: 31209779
[TBL] [Abstract][Full Text] [Related]
19. 89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies.
Verel I; Visser GW; Boellaard R; Stigter-van Walsum M; Snow GB; van Dongen GA
J Nucl Med; 2003 Aug; 44(8):1271-81. PubMed ID: 12902418
[TBL] [Abstract][Full Text] [Related]
20.
Verhoeff SR; van de Donk PP; Aarntzen EHJG; Oosting SF; Brouwers AH; Miedema IHC; Voortman J; Menke-van der Houven van Oordt WC; Boellaard R; Vriens D; Slingerland M; Hermsen R; Grunsven IVE; Heskamp S; van Herpen CML
J Nucl Med; 2022 Oct; 63(10):1523-1530. PubMed ID: 35512998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
